▪︎ CLP

CLP Regulation:
ECHA publishes guidance on new hazard classes

ECHA has updated the CLP guidelines to include the new hazard classes for endocrine disruptors and chemicals with long-lasting effects for the first time. The guidelines are an important guide for companies when assessing substances.

Industry demands clarity

The industry has long struggled with the uncertainty of how exactly the classification criteria should be applied, especially for endocrine disrupting chemicals. In fact, the urgency is great, as companies must evaluate new substances with regard to their endocrine disrupting properties and label them accordingly from May 1, 2025 in accordance with EU Regulation 2023/707. The industry also sees the lack of reliable data on endocrine disruptors as a problem.  

"Learning-by-doing approach

As there is a lack of experience with the risk assessment of substances with endocrine and long-term effects, ECHA favors a "learning by doing" approach. The Committee for Risk Assessment (RAC), which will issue opinions on endocrine disruptors from 2025, will play a key role in this. 

Prerequisite for classification

The guidance covers the classification of chemicals that are known to have endocrine disrupting effects on human health and the environment (Category 1) and those that are suspected of having endocrine disrupting effects (Category 2). There should be a biologically plausible link between the endocrine activity and the adverse effect. Consequently, all substances of very high concern due to their endocrine disrupting properties should be classified as Category 1 endocrine disrupting chemicals under the CLP Regulation.

What does endocrine effective mean?

Endocrine disrupting chemicals, also known as endocrine disruptors (EDs), are synthetic substances that act like the body's own hormones. They can therefore disrupt important developmental processes in the body and damage health. The best-known synthetic substances with an endocrine effect include bisphenol A and certain phthalates. Surfactants such as nonylphenol or some flame retardants from the group of polybrominated diphenyl ethers and polychlorinated biphenyls (PCBs) can also have hormone-like effects in the body.

Together with you, we analyze the status quo and plan the necessary steps. We will also advise you on the correct implementation of the labeling requirements. Please feel free to contact us at sales@kft.de.

KFT, your strong partner for chemical compliance solutions

Do you have any questions?